SMTL ID : 4w8e.1

Structure of MST3 with a pyrrolopyrimidine inhibitor (PF-06645342)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.79 Å

Oligo State

monomer

Ligands

1 x 3JB: 3-{4-[(2R)-2-(5-methyl-1,2,4-oxadiazol-3-yl)morpholin-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-5-yl}benzonitrile(Non-covalent)

3JB.1: 15 residues within 4Å: Chain A: I.22, G.23, K.24, G.25, S.26, V.30, A.43, K.45, E.62, M.91, E.92, Y.93, L.94, L.143, D.154 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.143, A:D.154 Hydrogen bonds: A:K.24, A:S.26, A:K.45, A:E.92, A:L.94, A:D.154 Water bridges: A:F.155

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Henderson, J.L. et al., Discovery and preclinical profiling of 3-[4-(morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), a highly potent, selective, brain penetrant, and in vivo active LRRK2 kinase inhibitor. J.Med.Chem. (2015)

Release Date

2015-03-18

Peptides

Serine/threonine-protein kinase 24 36 kDa subunit: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Serine/threonine-protein kinase 24 36 kDa subunit